Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells.

Saved in:
Bibliographic Details
Title: Galactosylceramide Upregulates the Expression of the BCL2 Gene and Downregulates the Expression of TNFRSF1B and TNFRSF9 Genes, Acting as an Anti-Apoptotic Molecule in Breast Cancer Cells.
Authors: Suchanski, Jaroslaw1 (AUTHOR) jaroslaw.suchanski@upwr.edu.pl, Reza, Safoura1 (AUTHOR), Urbaniak, Anna1 (AUTHOR), Woldanska, Weronika1 (AUTHOR), Kocbach, Bartlomiej1 (AUTHOR), Ugorski, Maciej1 (AUTHOR) maciej.ugorski@upwr.edu.pl
Source: Cancers. Jan2024, Vol. 16 Issue 2, p389. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers16020389